标题
Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
作者
关键词
-
出版物
Neuroscience Bulletin
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-20
DOI
10.1007/s12264-022-00836-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
- (2021) Joel Simrén et al. Alzheimers & Dementia
- Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
- (2021) Pratishtha Chatterjee et al. Translational Psychiatry
- Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer’s disease
- (2021) Yu-Hui Liu et al. Science Advances
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study
- (2021) Adam M. Brickman et al. Alzheimers & Dementia
- Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers
- (2021) Michelle M. Mielke et al. Alzheimers & Dementia
- Human tauopathy-derived tau strains determine the substrates recruited for templated amplification
- (2021) Airi Tarutani et al. BRAIN
- The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
- (2021) N. J. Ashton et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Higher Concentration of Plasma Glial Fibrillary Acidic Protein in Wilson Disease Patients With Neurological Manifestations
- (2021) Jie Lin et al. MOVEMENT DISORDERS
- How gut microbes could drive brain disorders
- (2021) Cassandra Willyard NATURE
- Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
- (2021) Simon Dujardin et al. NATURE MEDICINE
- Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
- (2021) Seung-Hye Lee et al. NEURON
- Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis
- (2021) Wenmin Xing et al. Frontiers in Aging Neuroscience
- Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
- (2021) Hem Prakash Karki et al. JOURNAL OF NANOBIOTECHNOLOGY
- The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease
- (2021) Patrycja Pawlik et al. Diagnostics
- Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease
- (2021) Daniel Asby et al. BRAIN
- Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
- (2021) Mehdi Eshraghi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- T217-Phosphorylation Exacerbates Tau Pathologies and Tau-Induced Cognitive Impairment
- (2021) Xin Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Infectious Disease Burden and the Risk of Alzheimer’s Disease: A Population-Based Study
- (2021) Antonios Douros et al. JOURNAL OF ALZHEIMERS DISEASE
- Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis
- (2021) Bruna Bellaver et al. NEUROLOGY
- Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
- (2021) Claudia Cicognola et al. Alzheimers Research & Therapy
- Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease
- (2021) Brittani R. Price et al. AGEING RESEARCH REVIEWS
- Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
- (2021) Yuanbing Jiang et al. Alzheimers & Dementia
- Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau
- (2021) Shorena Janelidze et al. Alzheimers & Dementia
- Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
- (2021) Pratishtha Chatterjee et al. Alzheimers & Dementia
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
- (2021) Joana B Pereira et al. BRAIN
- Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer’s Disease, Vascular Dementia, Psychobehavioral, and Functional Complications
- (2021) Michele Lauriola et al. JOURNAL OF ALZHEIMERS DISEASE
- GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance
- (2021) Kasper Katisko et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders
- (2021) Isabel Schulz et al. MOVEMENT DISORDERS
- Developing the ATX(N) classification for use across the Alzheimer disease continuum
- (2021) Harald Hampel et al. Nature Reviews Neurology
- Comparing the Clinical Utility and Diagnostic Performance of Cerebrospinal Fluid P-Tau181, P-Tau217 and P-Tau231 Assays
- (2021) Antoine Leuzy et al. NEUROLOGY
- CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study
- (2021) Marta Milà-Alomà et al. NEUROLOGY
- The Role of High Triglycerides Level in Predicting Cognitive Impairment: A Review of Current Evidence
- (2021) Alina Mihaela Dimache et al. Nutrients
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- (2021) Shorena Janelidze et al. JAMA Neurology
- Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
- (2021) Michelle M. Mielke et al. JAMA Neurology
- Investigating Changes in the Serum Inflammatory Factors in Alzheimer’s Disease and Their Correlation with Cognitive Function
- (2021) Jing Hao et al. JOURNAL OF ALZHEIMERS DISEASE
- Dysregulation of antimicrobial peptide expression distinguishes Alzheimer’s disease from normal aging
- (2020) Min Wang et al. Aging-US
- Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status
- (2020) June Kaplow et al. Alzheimers & Dementia
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Association of Polygenic Risk Score with Age at Onset and Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease in a Chinese Cohort
- (2020) Wei-Wei Li et al. Neuroscience Bulletin
- Accuracy of Biomarker Testing for Neuropathologically Defined Alzheimer Disease in Older Adults With Dementia
- (2020) Howard A. Fink et al. ANNALS OF INTERNAL MEDICINE
- Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
- (2020) Frank de Wolf et al. BRAIN
- Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study
- (2020) Young Chul Youn et al. JOURNAL OF ALZHEIMERS DISEASE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Nanoparticle-based immunomagnetic assay of plasma biomarkers for differentiating dementia and prodromal states of Alzheimer's disease – A cross-validation study
- (2020) Ming-Jang Chiu et al. Nanomedicine-Nanotechnology Biology and Medicine
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
- (2020) Erik C. B. Johnson et al. NATURE MEDICINE
- The implications of different approaches to define AT(N) in Alzheimer disease
- (2020) Niklas Mattsson-Carlgren et al. NEUROLOGY
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives
- (2020) Yuan Cheng et al. Translational Neurodegeneration
- Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
- (2020) Juan Lantero Rodriguez et al. ACTA NEUROPATHOLOGICA
- Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
- (2020) Longfei Jia et al. Alzheimers & Dementia
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer’s Disease: A Pilot Study
- (2020) Steinunn Thordardottir et al. JOURNAL OF ALZHEIMERS DISEASE
- Truncation of tau selectively facilitates its pathological activities
- (2020) Jianlan Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
- (2020) Juan Fortea et al. LANCET
- Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
- (2020) Gill Livingston et al. LANCET
- Serum albumin and beta-amyloid deposition in the human brain
- (2020) Jee Wook Kim et al. NEUROLOGY
- Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer’s disease.
- (2020) Marion Tible et al. NEUROLOGY
- Sex differences in CSF biomarkers vary by Alzheimer’s disease stage and APOE ε4 genotype
- (2020) Rosha Babapour Mofrad et al. NEUROLOGY
- CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation
- (2020) Kyu Hwan Shim et al. Alzheimers Research & Therapy
- Certification of Amyloid-Beta (Aβ) Certified Reference Materials by Amino Acid-Based Isotope Dilution High-Performance Liquid Chromatography Mass Spectrometry and Sulfur-Based High-Performance Liquid Chromatography Isotope Dilution Inductively Coupled Plasma Mass Spectrometry
- (2020) Liuxing Feng et al. ANALYTICAL CHEMISTRY
- Longitudinal plasma p-tau217 is increased in early stages of Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. BRAIN
- Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration
- (2020) Mar Pérez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer’s Disease
- (2020) Moira Marizzoni et al. JOURNAL OF ALZHEIMERS DISEASE
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias
- (2020) Jozef Hanes et al. NEUROLOGY
- Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and age
- (2020) Scott Ayton et al. PROGRESS IN NEUROBIOLOGY
- Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
- (2020) Inge M. W. Verberk et al. Alzheimers Research & Therapy
- Association between plasma exosome neurogranin and brain structure in patients with Alzheimer’s disease: a protocol study
- (2020) MengFei He et al. BMJ Open
- On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications
- (2020) Mikhail Inyushin et al. Frontiers in Immunology
- Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer’s Disease and Mild Cognitive Impairment: A Pilot Study
- (2020) Ali Yilmaz et al. Metabolites
- Defective mitophagy in Alzheimer’s disease
- (2020) Jangampalli Adi Pradeepkiran et al. AGEING RESEARCH REVIEWS
- Synaptic basis of Alzheimer’s disease: Focus on synaptic amyloid beta, P-tau and mitochondria
- (2020) Albin John et al. AGEING RESEARCH REVIEWS
- Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
- (2020) Thomas K. Karikari et al. Alzheimers & Dementia
- Immunity and amyloid beta, total tau and neurofilament light chain: Findings from a community‐based cohort study
- (2020) Lana Fani et al. Alzheimers & Dementia
- An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
- (2020) Carol Van Hulle et al. Alzheimers & Dementia
- Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
- (2020) Hendrik Wesseling et al. CELL
- Blood-Based ATN Biomarkers of Alzheimer’s Disease: A Meta-Analysis
- (2020) Ivan Koychev et al. JOURNAL OF ALZHEIMERS DISEASE
- Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
- (2020) Annika Öhrfelt et al. Alzheimers Research & Therapy
- Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
- (2020) Steffi De Meyer et al. Alzheimers Research & Therapy
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
- (2020) Shorena Janelidze et al. JAMA Neurology
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Recognition of the amyloid precursor protein by human γ-secretase
- (2019) Rui Zhou et al. SCIENCE
- Astrocyte Biomarkers in Alzheimer’s Disease
- (2019) Stephen F. Carter et al. TRENDS IN MOLECULAR MEDICINE
- Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults
- (2019) Rachel F. Buckley et al. JAMA Neurology
- Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment
- (2019) Raúl Loera-Valencia et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- APP processing and metabolism in corneal fibroblasts and epithelium as a potential biomarker for Alzheimer's disease
- (2019) Seung-il Choi et al. EXPERIMENTAL EYE RESEARCH
- Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease
- (2019) Nicolas R. Barthélemy et al. Frontiers in Aging Neuroscience
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia
- (2019) Clifford R. Jack et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma YKL-40 in the spectrum of neurodegenerative dementia
- (2019) Anna Villar-Piqué et al. Journal of Neuroinflammation
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
- (2019) Suzanne E. Schindler et al. NEUROLOGY
- Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid
- (2019) Longfei Jia et al. Alzheimers & Dementia
- Dementia in China: epidemiology, clinical management, and research advances
- (2019) Longfei Jia et al. LANCET NEUROLOGY
- Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias
- (2019) Anna Antonell et al. Alzheimers & Dementia
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Applying the ATN scheme in a memory clinic population
- (2019) Daniele Altomare et al. NEUROLOGY
- Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology
- (2019) Kaj Blennow et al. BRAIN
- A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer’s disease brain
- (2019) Ebru Ercan-Herbst et al. Acta Neuropathologica Communications
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- MFG-E8 inhibits Aβ-induced microglial production of cathelicidin-related antimicrobial peptide: A suitable target against Alzheimer’s disease
- (2018) Xiaotian Xu et al. CELLULAR IMMUNOLOGY
- Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer’s disease patients
- (2018) Jessyka Maria de França Bram et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
- (2018) Li Zhong et al. Molecular Neurodegeneration
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
- (2018) Eric McDade et al. NEUROLOGY
- Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
- (2018) Hua Zhang et al. Translational Neurodegeneration
- Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
- (2018) Åsa Sandelius et al. Alzheimers & Dementia
- Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic
- (2018) Harald Hampel et al. Nature Reviews Neurology
- Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
- (2017) Alison K. Ower et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies
- (2017) Ka Sing P Lai et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
- (2017) Franc Llorens et al. Molecular Neurodegeneration
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers
- (2017) Kaitlin B. Casaletto et al. NEUROLOGY
- Review: Tau in biofluids - relation to pathology, imaging and clinical features
- (2017) H. Zetterberg NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry
- (2016) Josef Pannee et al. Alzheimers & Dementia
- Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels—Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance
- (2016) Ye-Ran Wang et al. MOLECULAR NEUROBIOLOGY
- Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
- (2016) Amanda Heslegrave et al. Molecular Neurodegeneration
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
- (2016) Rawan Tarawneh et al. JAMA Neurology
- Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case–Control Study
- (2016) Zhi-Peng Xu et al. EBioMedicine
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?
- (2015) Guillermo Moya-Alvarado et al. MOLECULAR & CELLULAR PROTEOMICS
- Amyloid-β efflux from the central nervous system into the plasma
- (2014) Kaleigh Filisa Roberts et al. ANNALS OF NEUROLOGY
- Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series
- (2013) Gabor G. Kovacs et al. ACTA NEUROPATHOLOGICA
- Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis
- (2013) Sofia Lopes da Silva et al. Alzheimers & Dementia
- Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes
- (2013) Elaine Delvaux et al. NEUROBIOLOGY OF AGING
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
- (2008) Alex E. Roher et al. Alzheimers & Dementia
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started